Na LI, Xingbin HU, Jinmei XU, Zheng LIU, Yaozhen CHEN, Dandan YIN, Yazhou WANG, Ning AN, Fan WEN, Jiajia XIN, Hui-Jie ZHANG, Wen YIN

The Sca1+ mesenchymal stromal subpopulation promotes dendritic cell commitment in the niche

The hematopoietic microenvironment regulates self-renewal and differentiation of hematopoietic stem cells. Mesenchymal stromal cells (MSCs) contribute to the niche and participate in supporting dendritic cell (DC) commitment in vitro and in vivo. However, due to MSCs being heterogenic, it is necessary to understand the function of the MSC subpopulation in modulating the DC commitment. The current study showed that one of the bone-related Sca1+ MSCs enhanced bone marrow cell differentiation into DCs by direct cell-to-cell contact. Furthermore, the expression of STAT3 and STAT5 genes decreased in supernatant cells after Sca1+ MSCs were cocultured with bone marrow cells. In contrast, the expression level of caspase-3 in cells increased. At the same time, the presentation of costimulatory molecules CD80/CD86 and the migration of activated DCs towards lymph nodes were augmented by Sca1+ MSCs. The results demonstrated that the Sca1+ MSC subpopulation promotes the differentiation of bone marrow cells into DCs by direct cell-to-cell contact via STAT3/STAT5 and caspase-3 signaling. Meanwhile, Sca1+ MSCs also mediate the activation and migration capabilities of DCs.

PDF

___

Abdul-Ghani M, Megeney LA (2008). Rehabilitation of a contract killer: caspase-3 directs stem cell differentiation. Cell Stem Cell 2: 515-516.
Belz GT, Nutt SL (2012). Transcriptional programming of the dendritic cell network. Nat Rev Immunol 12: 101-113.
Chen Y, Chen Y, Yin D, Wang Y, Liu Z, An N, Wen F, Li N, Xin J, Hu X et al. (2016a). The Sca-1+ mesenchymal stromal cells modulate macrophage commitment and function. Turk J Biol 40: 473-483.
Chen Y, Yang J, Zhang HJ, Fan H, An N, Xin J, Li N, Xu J, Yin W, Wu Z et al. (2016b). Sca-1+ mesenchymal stromal cells inhibit splenic marginal zone B lymphocytes commitment through Caspase-3. Cell Biol Int 40: 549-559.
Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, Frassoni F, Bartolome ST, Sambuceti G, Traggiai E et al. (2011). Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. P Natl Acad Sci USA 108: 17384-17389.
Ding L, Morrison SJ (2013). Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495: 231-235.
Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012). Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457-462.
Esashi E, Wang YH, Perng O, Qin XF, Liu YJ, Watowich SS (2008). The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28: 509-520.
Frenette PS, Pinho S, Lucas D, Scheiermann C (2013). Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 31: 285-316.
Galderisi U, Giordano A (2014). The gap between the physiological and therapeutic roles of mesenchymal stem cells. Med Res Rev 34: 1100-1126.
Ganguly D, Haak S, Sisirak V, Reizis B (2013). The role of dendritic cells in autoimmunity. Nat Rev Immunol 13: 566-577.
Hammer GE, Ma A (2013). Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol 31: 743-791.
Hudson JE, Mills RJ, Frith JE, Brooke G, Jaramillo-Ferrada P, Wolvetang EJ, Cooper-White JJ (2011). A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Stem Cells Dev 20: 77-87.
Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120- 4126.
Lai HY, Yang MJ, Wen KC, Chao KC, Shih CC, Lee OK (2010). Mesenchymal stem cells negatively regulate dendritic lineage commitment of umbilical-cord-blood-derived hematopoietic stem cells: an unappreciated mechanism as immunomodulators. Tissue Eng Pt A 16: 2987-2997.
Laouar Y, Welte T, Fu XY, Flavell RA (2003). STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19: 903-912.
Lindenberg JJ, van de Ven R, Lougheed SM, Zomer A, Santegoets SJ, Griffioen AW, Hooijberg E, van den Eertwegh AJ, Thijssen VL, Scheper RJ et al. (2013). Functional characterization of a STAT3-dependent dendritic cell-derived CD14 cell population arising upon IL-10-driven maturation. Oncoimmunology 2: e23837.
Mabuchi Y, Morikawa S, Harada S, Niibe K, Suzuki S, RenaultMihara F, Houlihan DD, Akazawa C, Okano H, Matsuzaki Y (2013). LNGFR+THY-1+VCAM-1hi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Reports 1: 152-165.
Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Maayan A, Enikolopov GN, Frenette PS (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T et al. (2009). Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 206: 2483-2496.
Morrison SJ, Scadden DT (2014). The bone marrow niche for haematopoietic stem cells. Nature 505: 327-334.
Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ (2009). Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460: 259-263.
Onai N, Obata-Onai A, Tussiwand R, Lanzavecchia A, Manz MG (2006). Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J Exp Med 203: 227-238.
Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, Lin CP, Kronenberg HM, Scadden DT (2012). Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10: 259-272.
Satpathy AT, Wu X, Albring JC, Murphy KM (2012). Re(de)fining the dendritic cell lineage. Nat Immunol 13: 1145-1154.
Schraml BU, van Blijswijk J, Zelenay S, Whitney PG, Filby A, Acton SE, Rogers NC, Moncaut N, Carvajal JJ, Reis e Sousa C (2013). Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 154: 843-858. Seillet C, Belz GT (2013). Terminal differentiation of dendritic cells. Adv Immunol 120: 185-210.
Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009). MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583.
Sugiyama T, Kohara H, Noda M, Nagasawa T (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25: 977-988.
Wang YC, Hu XB, He F, Feng F, Wang L, Li W, Zhang P, Li D, Jia ZS, Liang YM et al. (2009). Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4. J Biol Chem 284: 15993-16003.
Wen F, Zhang HJ, Chen Y, Yue Q, Liu Z, Zhang Q, An N, Chen X, Li N, Xin J et al. (2015). Sca1 mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation. Int Immunopharmacol 26: 50-57.
Zhang B, Liu R, Shi D, Liu X, Chen Y, Dou X, Zhu X, Lu C, Liang W, Liao L et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 113: 46-57.